Sol-Gel Technologies (SLGL) Return on Sales (2018 - 2026)

Sol-Gel Technologies (SLGL) reported Return on Sales of 0.36% for Q1 2026, up 27.0% year-over-year from 0.28% in Q1 2025, and up 828.33% quarter-over-quarter from 0.05% in Q4 2025.

Sol-Gel Technologies (SLGL) Return on Sales (2018 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has 9 years of Return on Sales data on file, last reported at 0.36% in Q1 2026.

  • Return on Sales for Q1 2026 came in at 0.36%, up 27.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, up 1.0% from the prior year.
  • Return on Sales advanced to 0.36% in Q1 2026 per SLGL's latest filing, from 0.05% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.36% in Q1 2026 and troughed at 0.62% in Q4 2022.
  • A 5-year average of 0.08% and a median of 0.05% in 2025 frame the typical range for Return on Sales.
  • The sharpest annual moves came in 2022 and 2023: Return on Sales plunged 63 bps in 2022, then soared 50 bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 0.62% in 2022, then surged by 81 bps to 0.12% in 2023, then plunged by 81 bps to 0.22% in 2024, then soared by 78 bps to 0.05% in 2025, then surged by 828 bps to 0.36% in 2026.
  • Business Quant data shows SLGL's Return on Sales at 0.36% in Q1 2026, 0.05% in Q4 2025, and 0.16% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.00%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 0.00%
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.00%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Sol-Gel Technologies 207.80 Mn 197.67 Mn - 0.36%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.36%
Dec 31, 2025 -0.05%
Sep 30, 2025 -0.16%
Jun 30, 2025 0.01%
Mar 31, 2025 0.09%
Dec 31, 2024 -0.22%
Sep 30, 2024 0.00%
Jun 30, 2024 0.00%
Dec 31, 2023 -0.12%
Sep 30, 2023 -0.30%
Jun 30, 2023 -0.11%
Dec 31, 2022 -0.62%
Sep 30, 2022 -0.14%
Jun 30, 2022 0.00%
Mar 31, 2022 0.00%
Dec 31, 2021 0.01%
Sep 30, 2021 0.01%
Jun 30, 2021 0.09%
Mar 31, 2021 0.06%
Dec 31, 2020 -0.03%